Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, L. M.
Right arrow Articles by Gregory III, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, L. M.
Right arrow Articles by Gregory III, J. F.

The Journal of Nutrition Vol. 127 No. 12 December 1997, pp. 2321-2327
Copyright ©1997 by the American Society for Nutritional Sciences

A Dual-Label Stable-Isotopic Protocol Is Suitable for Determination of Folate Bioavailability in Humans: Evaluation of Urinary Excretion and Plasma Folate Kinetics of Intravenous and Oral Doses of [13C5] and [2H2]Folic Acid

Lisa M. Rogers, Christine M. Pfeiffer, Lynn B. Bailey, and Jesse F. Gregory III

Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611

Stable isotopic protocols for the study of folate absorption were conducted to determine the following: (1) the equivalence of the [13C5] and [2H2] forms of folic acid, and (2) the merits of short-term plasma kinetics from injected and oral doses vs. urinary excretion of [13C5] and [2H2]folates. Another objective was to evaluate the merits of protocols not involving "saturation" of subjects with nonlabeled folate. Oral administration of [13C5] and [2H2]folic acid (~500 nmol each) to adult subjects (n = 4) yielded an equivalent 24-h urinary excretion of ~2% of each dose (molar ratio of urinary [13C5]/[2H2]folates = 0.96 ± 0.055; mean ± SEM). Expression of urinary excretion as a ratio of [13C5]/[2H2]folates yielded less within-group variability than seen for absolute excretion of each form of labeled folate. In the second study, subjects received 226 nmol of [2H2]folic acid intravenously and 1010 nmol of [13C5]folic acid orally. Isotopic enrichment of plasma [2H2]folates rose rapidly and returned to near basal values by ~2 h postdose. In contrast, enrichment of plasma [13C5]folates was detected until 4 h after dose, whereas enrichment values were far lower than seen with [2H2]folate. Adjusting for the difference in dose, the molar response of plasma area under the curve for isotopic enrichment was 15- to 20-fold greater for injected folates. In view of this very limited short-term plasma response even with a relatively large oral dose, presumably due to hepatic first-pass uptake, these findings suggest that plasma kinetics would be of limited usefulness in assessing the relative bioavailability of nutritionally relevant oral doses of labeled folate.

Key words: folic acid, folate, human, bioavailability, stable isotopes.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. R Dainty, N. R Bullock, D. J Hart, A. T Hewson, R. Turner, P. M Finglas, and H. J Powers
Quantification of the bioavailability of riboflavin from foods by use of stable-isotope labels and kinetic modeling
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Melse-Boonstra, P. Verhoef, C. E West, J. A van Rhijn, R. B van Breemen, J. J. Lasaroms, S. D Garbis, M. B Katan, and F. J Kok
A dual-isotope-labeling method of studying the bioavailability of hexaglutamyl folic acid relative to that of monoglutamyl folic acid in humans by using multiple orally administered low doses.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1128 - 1133.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. J. A. Wright, P. M. Finglas, J. R. Dainty, C. A. Wolfe, D. J. Hart, D. M. Wright, and J. F. Gregory
Differential Kinetic Behavior and Distribution for Pteroylglutamic Acid and Reduced Folates: a Revised Hypothesis of the Primary Site of PteGlu Metabolism in Humans
J. Nutr., March 1, 2005; 135(3): 619 - 623.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. M Finglas, C. M Witthoft, L. Vahteristo, A. J. A. Wright, S. Southon, F. A. Mellon, B. Ridge, and P. Maunder
Use of an Oral/Intravenous Dual-Label Stable-Isotope Protocol to Determine Folic Acid Bioavailability from Fortified Cereal Grain Foods in Women
J. Nutr., May 1, 2002; 132(5): 936 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. F. Gregory III
Case Study: Folate Bioavailability
J. Nutr., April 1, 2001; 131(4): 1376S - 1382.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
A. M Boddie, E R. Dedlow, J. A Nackashi, F J. Opalko, G. P. Kauwell, J. F Gregory III, and L. B Bailey
Folate absorption in women with a history of neural tube defect-affected pregnancy
Am. J. Clinical Nutrition, July 1, 2000; 72(1): 154 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. F. Gregory III, J. Williamson, J.-F. Liao, L. B. Bailey, and J. P. Toth
Kinetic Model of Folate Metabolism in Nonpregnant Women Consuming [2H2]Folic Acid: Isotopic Labeling of Urinary Folate and the Catabolite para-Acetamidobenzoylglutamate Indicates Slow, Intake-Dependent, Turnover of Folate Pools
J. Nutr., November 1, 1998; 128(11): 1896 - 1906.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
J. F. Gregory III, J. Williamson, L. B. Bailey, and J. P. Toth
Urinary Excretion of [2H4]Folate by Nonpregnant Women Following a Single Oral Dose of [2H4]Folic Acid Is a Functional Index of Folate Nutritional Status
J. Nutr., November 1, 1998; 128(11): 1907 - 1912.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1997 by American Society for Nutrition